Literature DB >> 6841978

A hemolytic assay for clinical investigation of human C2.

F Joisel, I Leroux-Nicollet, J P Lebreton, M Fontaine.   

Abstract

The heat lability of early acting components of human complement was studied in detail. Kinetic disappearance of individual components was monitored by hemolytic assay. C2 and factor B were the most heat labile components. We took advantage of the difference in heat stability between C2 and C1 to develop a hemolytic assay for human C2.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6841978     DOI： 10.1016/0022-1759(83)90035-2

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN： 0022-1759            Impact factor:   2.303


  6 in total

1.  Inhibition of human complement by beta-glycyrrhetinic acid.

Authors:  B H Kroes; C J Beukelman; A J van den Berg; G J Wolbink; H van Dijk; R P Labadie
Journal:  Immunology       Date:  1997-01       Impact factor: 7.397

2.  Group IIA-Secreted Phospholipase A2 in Human Serum Kills Commensal but Not Clinical Enterococcus faecium Isolates.

Authors:  Fernanda L Paganelli; Helen L Leavis; Samantha He; Nina M van Sorge; Christine Payré; Gérard Lambeau; Rob J L Willems; Suzan H M Rooijakkers
Journal:  Infect Immun       Date:  2018-07-23       Impact factor: 3.441

3.  Alternative complement pathway and factor B activities in rats with altered blood levels of thyroid hormone.

Authors:  C S Bitencourt; C G Duarte; A E C S Azzolini; A I Assis-Pandochi
Journal:  Braz J Med Biol Res       Date:  2012-03-01       Impact factor: 2.590

4.  RNA-seq and Tn-seq reveal fitness determinants of vancomycin-resistant Enterococcus faecium during growth in human serum.

Authors:  Xinglin Zhang; Vincent de Maat; Ana M Guzmán Prieto; Tomasz K Prajsnar; Jumamurat R Bayjanov; Mark de Been; Malbert R C Rogers; Marc J M Bonten; Stéphane Mesnage; Rob J L Willems; Willem van Schaik
Journal:  BMC Genomics       Date:  2017-11-21       Impact factor: 3.969

5.  Alpha-synuclein activates the classical complement pathway and mediates complement-dependent cell toxicity.

Authors:  Emil Gregersen; Cristine Betzer; Woojin S Kim; Gergo Kovacs; Lasse Reimer; Glenda M Halliday; Steffen Thiel; Poul Henning Jensen
Journal:  J Neuroinflammation       Date:  2021-08-16       Impact factor: 8.322

6.  Identification of a staphylococcal complement inhibitor with broad host specificity in equid Staphylococcus aureus strains.

Authors:  Nienke W M de Jong; Manouk Vrieling; Brandon L Garcia; Gerrit Koop; Matt Brettmann; Piet C Aerts; Maartje Ruyken; Jos A G van Strijp; Mark Holmes; Ewan M Harrison; Brian V Geisbrecht; Suzan H M Rooijakkers
Journal:  J Biol Chem       Date:  2018-02-05       Impact factor: 5.157
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.